非计划剖宫产术前阴道清洁减少感染:一项随机临床试验
该随机临床试验于2015年8月3日至2021年1月28日纳入608例分娩后接受剖宫产的患者,按1:1随机分为腹部清洁加1%聚维酮碘阴道清洁组与单纯腹部清洁组,比较术后30天内复合感染发病率。结果显示两组主要复合结局无显著差异(11.8% vs 11.5%;P=.90;相对风险,1.0;95%置信区间,0.7-1.6),结论认为阴道清洁未减少术后感染发病率,不支持常规使用。
要点
- 分娩后剖宫产术前1%聚维酮碘阴道清洁未降低术后30天复合感染发病率。
- 主要复合结局阴道清洁组11.8% vs 对照组11.5%,无显著差异(P=.90)。
- 结论不支持对分娩后剖宫产女性常规行阴道清洁。
核心结论
- 分娩后非计划剖宫产术前使用聚维酮碘行阴道清洁未减少术后感染发病率,这些发现不支持常规使用阴道清洁。
研究设计与样本
- 随机临床试验,于2015年8月3日至2021年1月28日开展,随访30天,最终随访于2021年2月27日完成。
- 纳入标准为规律宫缩伴宫颈扩张后、胎膜破裂后或宫颈扩张大于4厘米时实施的剖宫产。
- 共608例受试者(阴道清洁组304例,对照组304例)纳入意向性治疗分析,按1:1随机分配至腹部清洁加1%聚维酮碘阴道清洁组或单纯腹部清洁组。
主要发现
- 主要复合结局(剖宫产术后30天内手术部位感染、发热、子宫内膜炎和伤口并发症)在两组间无显著差异(11.8% vs 11.5%;P=.90;相对风险,1.0;95%置信区间,0.7-1.6)。
- 复合结局的各个组分及次要结局在两组间亦无显著差异。
- 符合方案分析观察到相似结果(11.3% vs 11.8%;P=.9;相对风险,1.0;95%置信区间,0.7-1.6)。
临床怎么用
- 原文结论为这些发现不支持对分娩后剖宫产女性常规使用阴道清洁。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Cesarean delivery is the most performed major surgery among women, and surgical-site infections following a cesarean delivery are a significant source of postoperative morbidity. It is unclear if vaginal cleansing before a cesarean delivery decreases post-cesarean delivery infectious morbidity. OBJECTIVE: This study aimed to evaluate if preoperative vaginal cleansing with povidone-iodine among women undergoing a cesarean delivery after labor decreases postoperative infectious morbidity. STUDY DESIGN: This randomized clinical trial was conducted from August 3, 2015 to January 28, 2021, with 30 days of follow-up and the final follow-up completed on February 27, 2021. Patients met the inclusion criteria if they underwent a cesarean delivery after regular contractions with cervical dilation, rupture of membranes, or any cesarean delivery performed at >4 cm dilation. Participants were randomly assigned in a 1:1 ratio to either abdominal cleansing plus vaginal cleansing with 1% povidone-iodine or abdominal cleansing alone. The primary outcome was composite infectious morbidity including surgical-site infection, fever, endometritis, and wound complications within 30 days after the cesarean delivery. Secondary outcomes included individual components of the composite, length of hospital stay, postoperative hospitalization or outpatient treatment related to infectious morbidity, and empirical treatment for neonatal sepsis. RESULTS: A total of 608 subjects (304 vaginal cleansing group, 304 control group) were included in the intention-to-treat analysis. Patient characteristics were similar between groups. There was no significant difference in the primary composite outcome between the 2 groups (11.8% vs 11.5%; P=.90; relative risk, 1.0; 95% confidence interval, 0.7-1.6). Individual components of the composite and secondary outcomes were also not significantly different between the groups. Similar findings were observed in the as-treated analysis (11.3% vs 11.8%; P=.9; relative risk, 1.0; 95% confidence interval, 0.7-1.6). CONCLUSION: Vaginal cleansing with povidone-iodine before an unscheduled cesarean delivery occurring after labor did not reduce the postoperative infectious morbidity. These findings do not support the routine use of vaginal cleansing for women undergoing a cesarean delivery after labor.
引用
- Temming LA, Frolova AI, Raghuraman N, et al. Vaginal cleansing before unscheduled cesarean delivery to reduce infection: a randomized clinical trial. Am J Obstet Gynecol. 2022. PMID: 36462539. doi:10.1016/j.ajog.2022.11.1300
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。